Cancer

Name Project Details Contact
Professor Ian Frazer
  • Regulation of effector T cells by the innate immune response
  • Immunotherapy for virus associated skin cancer
  • Cervical cancer control in Vanuatu
Phone
+61 7 3346 1905
Email
wendy.freeman@tri.edu.au
Associate Professor Brian Gabrielli
  • Identifying the molecular basis for defective checkpoints in melanoma.
  • Targeting defective cell cycle responses to ultraviolet radiation and TopoII inhibitors in melanoma.
  • Defining the molecular changes in moles underpinning morphological changes detectable by non-invasive imaging techniques to improve their diagnostic and prognostic ability for early stage melanoma.
Phone
+61 7 3176 7129
Email
briang@uq.edu.au
Dr Angus Harding
  • Combining computer models and clinical data to understand, treat and prevent brain cancer
Phone
+61 7 3176 5285
Email
a.harding1@uq.edu.au
Dr Michelle Hill
  • Cancer microvesicles as a source of biomarkers and novel target of anti-cancer therapy
  • Systems biology approach to understand lipid raft and caveolin function in health and disease
  • Discovery and validation of novel salivary and blood biomarkers for head and neck cancers using lectin magnetic bead array-mass spectrometry, LeMBA-MS (with Dr Chamindie Punyadeera)
  • NPM functions associated with acute myeloid leukemia (with Dr Kerry Inder)
Phone
+61 7 3176 7456
Email
m.hill2@uq.edu.au
Dr Graham Leggatt
  • Trafficking of T cells to cancerous skin
  • Immunotherapy of skin tumours after lymphodepletion
  • T cell function in normal and cancerous skin tissue
Phone
+61 7 3176 5281
Email
g.leggatt@uq.edu.au
Dr Stephen Mattarollo
  • NKT cell immune adjuvant-based therapeutic vaccination in a mouse model of B cell lymphoma
  • Combination immunotherapies against haematological malignancies
  • Mechanisms of tumor resistance against immune-based therapies
  • Susceptibility of autoimmune-prone mice to tumor development
  • Impact of endocytosis inhibitors on monoclonal antibody-based immunotherapeutics against cancer
  • Localized immune suppressive mechanisms in HPV-associated pre-cancers
Phone:
+61 7 3176 6943
Email
s.mattarollo@uq.edu.au
Associate Professor Nicholas Saunders
  • Understanding the molecular basis for the control of squamous differentiation
  • Understanding how these processes are dysregulated during the development of oral and skin cancers
  • Exploiting this knowledge in the development of novel treatments for skin cancers and oral cancer
  • Interrogating chemotherapeutic sensitivity
  • Identifying novel strategies to treat metastatic osteosarcoma
Phone
+61 7 3176 5984
Email
nsaunders@uq.edu.au
Dr Fiona Simpson
  • Epidermal growth factor trafficking in squamous cell carcinoma and its impact on patient treatment with anti-EGFR inhibitors
  • Girdin, Daple and Gipie, the HkRP family in trafficking and Oncogenesis
Phone
+61 7 3176 7456
Email
f.simpson@uq.edu.au
Dr James Wells
  • Immunotherapy for the treatment of established skin cancer
  • Requirements for the initiation and treatment of Non-Melanoma skin cancer
  • Immunophenotyping squamous skin cancer
  • Immunological identifiers of skin pathology
Phone
+61 7 3176 5315
Email
j.wells3@uq.edu.au

Autoimmunity

Name Project Details Contact
Dr Antje Blumenthal
  • Innate immune recognition of Mycobacterium tuberculosis and other pathogens
  • Molecular mechanisms of macrophage functions
  • Regulators of immune responses during infection and inflammation
  • Discovery of novel anti-microbials against tuberculosis
Phone
+61 3176 2926
Email
a.blumenthal@uq.edu.au
Professor Matt Brown
  • Genetics of common bone and joint diseases
  • Osteoporosis
  • Interethnic mapping of common human diseases; ankylosing spondylitis, rheumatoid arthritis, schizophrenia
  • ENU mutagenesis and models of musculoskeletal diseases
  • Gene deserts involved in ankylosing spondylitis
  • Genetics of multiple sclerosis
  • Novel gene-mapping approaches using next-generation sequencing
Phone
+61 7 3176 5954
Email
di.director@uq.edu.au
Dr Emma Hamilton-Williams
  • A novel role for the interleukin-2 pathway in humans and mouse models of type 1 diabetes
  • Genetic control of intestinal microflora in type 1 diabetes susceptibility
  • Impaired Regulatory T cell function in type 1 diabetes
Phone
+61 7 3176 5392
Email
e.hamiltonwilliams@uq.edu.au
Dr Tony Kenna
  • Functional characterisation of genetic variants in the IL23R pathway associated with ankylosing spondylitis
Phone
+61 7 3176 5832
Email
t.kenna@uq.edu.au
Dr Ray Steptoe
  • Cellular and molecular pathways of T-cell tolerance
  • Prevention and reversal of autoimmune diabetes
  • Novel methods of gene delivery for tolerance
  • Immunotherapy of allergies and anaphylaxis
Phone
+61 7 3176 5393
Email
r.steptoe@uq.edu.au
Dr Gethin Thomas
  • Gene expression profiling in ankylosing spondylitis
  • Identification of novel genes in skeletal disease through large-scale ENU mouse mutagenesis
  • Novel treatment approaches to prevent joint fusion in ankylosing spondylitis
  • Elucidation of basis for “gene desert” associations with ankylosing spondylitis
Phone
+61 7 3176 2755
Email
gethin.thomas@uq.edu.au
Professor Ranjeny Thomas
  • Understanding the molecular control of dendritic cell function in tolerance
  • Initiation of inflammatory arthritis
  • Rheumatoid arthritis antigen-specific therapy
  • Type 1 (Juvenile) Diabetes Innate Immunity: mouse models and human longitudinal study
  • Use of statins to reduce atherosclerosis in early rheumatoid arthritis
Phone
+61 7 3176 5365
Email
ranjeny.thomas@uq.edu.au
Professor Peter Visscher
  • Heritability of gene expression
  • Statistical methods and applications using SNP data to test whether risk factors for disease are causative
  • Understanding the genetic architecture of complex traits
    through analysis of DNA sequence data
  • Development and application of risk prediction models for
    common diseases
Phone
+61 7 3346 1814
Email
peter.visscher@uq.edu.au

 

Go to top